| Intrinsic Valuation of: VRSK | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 7 | Market Cap | $44B | |||||
| 2021 | - | - (-) | P/E Ratio | 46 | Total Asset | $4B | |||||
| 2022 | $887M | - (-) | Net Income | $958M | Total Debt | $3B | |||||
| 2023 | $784M | -11.6% (-12.8%) | EBITDA | $2B | Total Liab | $4B | |||||
| 2024 | $831M | 5.9% (-1.4%) | Opr Margin | 0.44 | Debt/Equity | 24.00 | |||||
| 2025 | $920M | 10.8% (3.1%) | PreTax Margin | 39.19 | BV/Share | -14 | |||||
| 5Y Average FCF | $856M | 1.7% (-3.7%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | $957M | MBG Intrinsic Value | $61 | ||||||||
| 2027 | $995M | ||||||||||
| 2028 | $1B | ||||||||||
| 2029 | $1B | ||||||||||
| 2030 | $1B | ||||||||||
| 2031 | $1B | ||||||||||
| Terminal Value | $24B | Net Worth/Share | $1 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $21B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $291M | $132 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $3B | WACC | 7.3% | 114 | 124 | 135 | 149 | 167 | |||
| Equity Value | $18B | 7.4% | 113 | 122 | 133 | 147 | 164 | ||||
| Shares Outstanding | 139,884,000 | 7.4% | 112 | 121 | 132 | 145 | 162 | ||||
| 7.9% | 102 | 109 | 118 | 129 | 142 | ||||||
| DCF Intrinsic Value | $132 | 8.4% | 93 | 99 | 107 | 115 | 126 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||